Anticholinergic Toxidrome as a Possible Explanation for Methylene Blue Toxicity (2023)

Peer-Reviewed Study · Aldeghaither S, Deschênes PJF, Samoukovic G · November 15, 2023

Aldeghaither S et al., 2023-11-15: Case report of a man in his mid-sixties who developed anuria, fever and bilateral mydriasis after high-dose methylene blue for post-cardiac-surgery vasoplegia; the authors argue an anticholinergic toxidrome explains methylene blue neurological toxicity at high doses, especially with renal failure.

The patient became anuric and febrile, with bilateral mydriasis. Internal cooling and continuous renal replacement therapy were initiated, and symptoms rapidly resolved.

Aldeghaither S et al., 2023-11-15: Case report of a man in his mid-sixties who developed anuria, fever and bilateral mydriasis after high-dose methylene blue for post-cardiac-surgery vasoplegia; the authors argue an anticholinergic toxidrome explains methylene blue neurological toxicity at high doses, especially with renal failure. C5 neurological effects and C7 renal element. Dose/route: intravenous methylene blue at "a high dose" for refractory vasoplegia – the abstract does not give mg/kg; the patient required continuous renal replacement therapy and was discharged with a permanent dialysis catheter. Funder/conflicts not stated in abstract. Comparator: none. Authors advise caution with other anticholinergic drugs and in renal failure. Also filed as MTE-46 (claims C11, C5). Study type: case report.